[ESPR] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
02-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -58.89%
YoY- 18.79%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 18,841 18,836 15,401 14,409 40,659 7,978 9,638 56.53%
PBT -66,324 -56,731 -65,119 -69,386 -43,668 -90,935 -104,476 -26.19%
Tax 13,948 13,742 13,430 13,667 11,153 8,139 8,795 36.10%
NP -80,272 -70,473 -65,119 -69,386 -43,668 -90,935 -104,476 -16.15%
Tax Rate - - - - - - - -
Total Cost 99,113 89,309 80,520 83,795 84,327 98,913 114,114 -8.99%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -426.05 -374.14 -422.82 -481.55 -107.40 -1,139.82 -1,084.00 -46.43%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -1.27 -1.16 -1.77 -2.62 -1.67 -3.50 -3.89 -52.68%
EPS Diluted -1.27 -1.16 -1.77 -2.62 -1.67 -3.50 -3.89 -52.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.